The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation

Journal of Cellular Physiology

Volumn 230, Issue 11, 2015, Pages 2683-2694

  Wu, Qiong ^a   Madany, Pasil ^a   Akech, Jacqueline ^a   Dobson, Jason R ^a,b,c   Douthwright, Stephen ^a   Browne, Gillian ^a,d   Colby, Jennifer L ^a   Winter, Georg E ^e   Bradner, James E ^e,f   Pratap, Jitesh ^a,g   Sluder, Greenfield ^a   Bhargava, Rohit ^h   Chiosea, Simion I ⁱ   van Wijnen, Andre J ^a,j   Stein, Janet L ^a,d   Stein, Gary S ^a,d   Lian, Jane B ^a,d   Nickerson, Jeffrey A ^a   Imbalzano, Anthony N ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c Brown Univerity   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g RUSH MEDICAL COLLEGE   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^j MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; BRM PROTEIN; CRISPR ASSOCIATED PROTEIN; DOXYCYCLINE; SHORT HAIRPIN RNA; VIRUS VECTOR; ADENOSINE TRIPHOSPHATASE; DNA HELICASE; NUCLEAR PROTEIN; SMARCA2 PROTEIN, HUMAN; SMARCA4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL ASSESSMENT; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; TREATMENT INDICATION; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; CRISPR CAS SYSTEM; FEMALE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; PATHOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CRISPR-CAS SYSTEMS; DNA HELICASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; MICE; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84937915068     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24991     Document Type: Article

References (82)

1. Bai J, Mei P, Zhang C, Chen F, Li C, Pan Z, Liu H, Zheng J. 2013. BRG1 is a prognostic marker and potential therapeutic target in human breast cancer. PLoS One 8:e59772.
2. Bartholomew B. 2014. Regulating the chromatin landscape: Structural and mechanistic perspectives. Annu Rev Biochem 83:671-696.
3. Bishop JM. 1981. Enemies within: The genesis of retrovirus oncogenes. Cell 23:5-6.
4. Blanco R, Iwakawa R, Tang M, Kohno T, Angulo B, Pio R, Montuenga LM, Minna JD, Yokota J, Sanchez-Cespedes M. 2009. A gene-alteration profile of human lung cancer cell lines. Human mutation 30:1199-1206.
5. Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R. 2000. BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer. Cell 102:257-265.
6. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, Randazzo F, Metzger D, Chambon P, Crabtree G, Magnuson T. 2000. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6:1287-1295.
7. Bultman SJ, Herschkowitz JI, Godfrey V, Gebuhr TC, Yaniv M, Perou CM, Magnuson T. 2008. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 27:460-468.
8. Buscarlet M, Krasteva V, Ho L, Simon C, Hebert J, Wilhelm B, Crabtree GR, Sauvageau G, Thibault P, Lessard JA. 2014. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood 123:1720-1728.
9. Cailleau R, Olive M, Cruciger QV. 1978. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14:911-915.
10. Cairns RA, Harris IS, Mak TW. 2011. Regulation of cancer cell metabolism. Nat Rev Cancer 11:85-95.
11. Cohet N, Stewart KM, Mudhasani R, Asirvatham AJ, Mallappa C, Imbalzano KM, Weaver VM, Imbalzano AN, Nickerson JA. 2010. SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells. J Cell Physiol 223:667-678.
12. Damiano L, Stewart KM, Cohet N, Mouw JK, Lakins JN, Debnath J, Reisman D, Nickerson JA, Imbalzano AN, Weaver VM. 2014. Oncogenic targeting of BRM drives malignancy through C/EBPbeta-dependent induction of alpha5 integrin. Oncogene 33:2441-2453.
13. de la Serna IL, Ohkawa Y, Imbalzano AN. 2006. Chromatin remodelling in mammalian differentiation: Lessons from ATP-dependent remodellers. Nat Rev Genet 7:461-473.
14. Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. 2001. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol 186:136-145.
15. Dingemans AM, van den Boogaart V, Vosse BA, van Suylen RJ, Griffioen AW, Thijssen VL. 2010. Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer. Mol Cancer 9:152.
16. Domfeh AB, Carley AL, Striebel JM, Karabakhtsian RG, Florea AV, McManus K, Beriwal S, Bhargava R. 2008. WT1 immunoreactivity in breast carcinoma: Selective expression in pure and mixed mucinous subtypes. Mod Pathol 21:1217-1223.
17. Du W, Elemento O. 2014. Cancer systems biology: Embracing complexity to develop better anticancer therapeutic strategies. Oncogene. doi: 10.1038/onc.2014.291
18. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP. 1994. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119-130.
19. Euskirchen G, Auerbach RK, Snyder M. 2012. SWI/SNF chromatin-remodeling factors: Multiscale analyses and diverse functions. J Biol Chem 287:30897-30905.
20. Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, Hewitt S, Travis WD, Jen J. 2004. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res 10:4314-4324.
21. Gentles AJ, Gallahan D. 2011. Systems biology: Confronting the complexity of cancer. Cancer Res 71:5961-5964.
22. Glaros S, Cirrincione GM, Muchardt C, Kleer CG, Michael CW, Reisman D. 2007. The reversible epigenetic silencing of BRM: Implications for clinical targeted therapy. Oncogene 26:7058-7066.
23. Guidi CJ, Sands AT, Zambrowicz BP, Turner TK, Demers DA, Webster W, Smith TW, Imbalzano AN, Jones SN. 2001. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol 21:3598-3603.
24. Hargreaves DC, Crabtree GR. 2011. ATP-dependent chromatin remodeling: Genetics, genomics and mechanisms. Cell Res 21:396-420.
25. Harris H, Miller OJ, Klein G, Worst P, Tachibana T. 1969. Suppression of malignancy by cell fusion. Nature 223:363-368.
26. Helming KC, Wang X, Roberts CW. 2014. Vulnerabilities of mutant SWI/SNF complexes in cancer. Cancer Cell 26:309-317.
27. Hendricks KB, Shanahan F, Lees E. 2004. Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol 24:362-376.
28. Hill DA, de la Serna IL, Veal TM, Imbalzano AN. 2004. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2. J Cell Biochem 91:987-998.
29. Ho L, Crabtree GR. 2010. Chromatin remodelling during development. Nature 463:474-484.
30. Hohmann AF, Vakoc CR. 2014. A rationale to target the SWI/SNF complex for cancer therapy. Trends Genet 30:356-363.
31. Huebner RJ, Todaro GJ. 1969. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 64:1087-1094.
32. Imbalzano KM, Cohet N, Wu Q, Underwood JM, Imbalzano AN, Nickerson JA. 2013. Nuclear shape changes are induced by knockdown of the SWI/SNF ATPase BRG1 and are independent of cytoskeletal connections. PLoS ONE 8:e55628.
33. Jones DT, Jager N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stutz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, Pleier S, Cin H, Pfaff E, Sieber L, Wittmann A, Remke M, Witt H, Hutter S, Tzaridis T, Weischenfeldt J, Raeder B, Avci M, Amstislavskiy V, Zapatka M, Weber UD, Wang Q, Lasitschka B, Bartholomae CC, Schmidt M, von Kalle C, Ast V, Lawerenz C, Eils J, Kabbe R, Benes V, van Sluis P, Koster J, Volckmann R, Shih D, Betts MJ, Russell RB, Coco S, Tonini GP, Schuller U, Hans V, Graf N, Kim YJ, Monoranu C, Roggendorf W, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, von Deimling A, Witt O, Maass E, Rossler J, Ebinger M, Schuhmann MU, Fruhwald MC, Hasselblatt M, Jabado N, Rutkowski S, von Bueren AO, Williamson D, Clifford SC, McCabe MG, Collins VP, Wolf S, Wiemann S, Lehrach H, Brors B, Scheurlen W, Felsberg J, Reifenberger G, Northcott PA, Taylor MD, Meyerson M, Pomeroy SL, Yaspo ML, Korbel JO, Korshunov A, Eils R, Pfister SM, Lichter P. 2012. Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100-105.
34. Kadam S, Emerson BM. 2003. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell 11:377-389.
35. Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree GR. 2013. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 45:592-601.
36. Keenen B, Qi H, Saladi SV, Yeung M, de la Serna IL. 2010. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma. Oncogene 29:81-92.
37. Klein G. 1987. The approaching era of the tumor suppressor genes. Science 238:1539-1545.
38. Klinger HP. 1982. Suppression of tumorigenicity. Cytogenet Cell Genet 32:68-84.
39. Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M. 2000. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep 1:500-506.
40. Kwon H, Imbalzano AN, Khavari PA, Kingston RE, Green MR. 1994. Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature 370:477-481.
41. Lee D, Kim JW, Seo T, Hwang SG, Choi EJ, Choe J. 2002. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 277:22330-22337.
42. Lee EY, Muller WJ. 2010. Oncogenes and tumor suppressor genes. Cold Spring Harb Perspect Biol 2:a003236.
43. Levine AJ, Oren M. 2009. The first 30 years of p53: Growing ever more complex. Nat Rev Cancer 9:749-758.
44. Lin H, Wong RP, Martinka M, Li G. 2010. BRG1 expression is increased in human cutaneous melanoma. Br J Dermatol 163:502-510.
45. Liu N, Balliano A, Hayes JJ. 2011. Mechanism(s) of SWI/SNF-induced nucleosome mobilization. Chembiochem 12:196-204.
46. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. 2012. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44:1321-1325.
47. Medina PP, Carretero J, Fraga MF, Esteller M, Sidransky D, Sanchez-Cespedes M. 2004. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Genes Chromosomes Cancer 41:170-177.
48. Medina PP, Romero OA, Kohno T, Montuenga LM, Pio R, Yokota J, Sanchez-Cespedes M. 2008. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Human mutation 29:617-622.
49. Muchardt C, Bourachot B, Reyes JC, Yaniv M. 1998. Ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex. EMBO J 17:223-231.
50. Naidu SR, Love IM, Imbalzano AN, Grossman SR, Androphy EJ. 2009. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene 28:2492-2501.
51. Nam JM, Onodera Y, Bissell MJ, Park CC. 2010. Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Res 70:5238-5248.
52. Network TCGA 2012. Comprehensive molecular portraits of human breast tumours. Nature 490:61-70.
53. Phelan ML, Sif S, Narlikar GJ, Kingston RE. 1999. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3:247-253.
54. Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel, Bochicchio D, Carneiro J, Carter MO, Cibulskis SL, Erlich K, Greulich RL, Lawrence H, Lennon MS, McKenna NJ, Meldrim A, Ramos J, Ross AH, Russ MG, Shefler C, Sivachenko E, Sogoloff A, Stojanov B, Tamayo P, Mesirov P, Amani JP, Teider V, Sengupta N, Francois S, Northcott JP, Taylor PA, Yu MD, Crabtree F, Kautzman GR, Gabriel AG, Getz SB, Jager G, Jones N, Lichter DT, Pfister P, Roberts SM, Meyerson TM, Pomeroy M, Cho SL, 2012. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106-110.
55. Reisman D, Glaros S, Thompson EA. 2009. The SWI/SNF complex and cancer. Oncogene 28:1653-1668.
56. Reisman DN, Sciarrotta J, Bouldin TW, Weissman BE, Funkhouser WK. 2005. The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues. Appl Immunohistochem Mol Morphol 13:66-74.
57. Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. 2003. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: Correlation with poor prognosis. Cancer Res 63:560-566.
58. Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W, Jr., Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE. 2002. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: Differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21:1196-1207.
59. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. 1998. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J 17:6979-6991.
60. Roberts CW, Galusha SA, McMenamin ME, Fletcher CD, Orkin SH. 2000. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci USA 97:13796-13800.
61. Rodriguez-Nieto S, Canada A, Pros E, Pinto AI, Torres-Lanzas J, Lopez-Rios F, Sanchez-Verde L, Pisano DG, Sanchez-Cespedes M. 2011. Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors. Human mutation 32:E1999-E2017.
62. Romero OA, Torres-Diz M, Pros E, Savola S, Gomez A, Moran S, Saez C, Iwakawa R, Villanueva A, Montuenga LM, Kohno T, Yokota J, Sanchez-Cespedes M. 2014. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1. Cancer Discov 4:292-303.
63. Rous P. 1911. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13:397-411.
64. Sager R. 1986. Genetic suppression of tumor formation: A new frontier in cancer research. Cancer Res 46:1573-1580.
65. Saladi SV, Keenen B, Marathe HG, Qi H, Chin KV, de la Serna IL. 2010. Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness. Mol Cancer 9:280.
66. Sentani K, Oue N, Kondo H, Kuraoka K, Motoshita J, Ito R, Yokozaki H, Yasui W. 2001. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas. Pathobiology 69:315-320.
67. Serber DW, Rogala A, Makarem M, Rosson GB, Simin K, Godfrey V, Van Dyke T, Eaves CJ, Bultman SJ. 2012. The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner. PLoS ONE 7:e31346.
68. Shain AH, Pollack JR. 2013. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS ONE 8:e55119.
69. Sherr CJ. 2004. Principles of tumor suppression. Cell 116:235-246.
70. Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe JS, Minder JL, Mercan F, Wang E, Eckersley-Maslin MA, Campbell AE, Kawaoka S, Shareef S, Zhu Z, Kendall J, Muhar M, Haslinger C, Yu M, Roeder RG, Wigler MH, Blobel GA, Zuber J, Spector DL, Young RA, Vakoc CR. 2013. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev 27:2648-2662.
71. Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES. 2000. BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 97:7748-7753.
72. Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, Li B. 2007. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate 67:203-213.
73. Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P. 2006. A versatile tool for conditional gene expression and knockdown. Nat Methods 3:109-116.
74. Trouche D, Le Chalony C, Muchardt C, Yaniv M, Kouzarides T. 1997. RB and hbrm cooperate to repress the activation functions of E2 F1. Proc Natl Acad Sci USA 94:11268-11273.
75. Tuveson DA, Jacks T. 1999. Modeling human lung cancer in mice: Similarities and shortcomings. Oncogene 18:5318-5324.
76. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR. 1996. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 15:5370-5382.
77. Watanabe T, Semba S, Yokozaki H. 2011. Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells. Br J Cancer 104:146-154.
78. Weinberg RA. 1983. Alteration of the genomes of tumor cells. Cancer 51:1971-1975.
79. Wiener F, Klein G, Harris H. 1974. The analysis of malignancy by cell fusion. V. Further evidence of the ability of normal diploid cells to suppress malignancy. J Cell Sci 15:177-183.
80. Wu JI. 2012. Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer. Acta Biochim Biophys Sin (Shanghai) 44:54-69.
81. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. 2007. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 67:659-664.
82. Zhang H, Cohen SN. 2004. Smurf2 up-regulation activates telomere-dependent senescence. Genes Dev 18:3028-3040.